Collegium Pharmaceutical (COLL) Net Margin (2016 - 2025)
Historic Net Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 15.05%.
- Collegium Pharmaceutical's Net Margin rose 91900.0% to 15.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.72%, marking a year-over-year decrease of 70600.0%. This contributed to the annual value of 6.71% for FY2024, which is 14100.0% down from last year.
- Latest data reveals that Collegium Pharmaceutical reported Net Margin of 15.05% as of Q3 2025, which was up 91900.0% from 6.37% recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Net Margin registered a high of 89.23% during Q2 2021, and its lowest value of 91.49% during Q4 2021.
- In the last 5 years, Collegium Pharmaceutical's Net Margin had a median value of 6.89% in 2024 and averaged 5.49%.
- In the last 5 years, Collegium Pharmaceutical's Net Margin tumbled by -1006100bps in 2021 and then surged by 859400bps in 2022.
- Quarter analysis of 5 years shows Collegium Pharmaceutical's Net Margin stood at 91.49% in 2021, then soared by 94bps to 5.55% in 2022, then soared by 484bps to 21.33% in 2023, then plummeted by -68bps to 6.89% in 2024, then skyrocketed by 118bps to 15.05% in 2025.
- Its Net Margin was 15.05% in Q3 2025, compared to 6.37% in Q2 2025 and 1.36% in Q1 2025.